Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammation across the spectrum of hypertrophic cardiac phenotypes
Rosa Lillo, Francesca Graziani, Francesco Franceschi, et al.
Heart Failure Reviews (2023) Vol. 28, Iss. 5, pp. 1065-1075
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Prevalence of Pathogenic Variants in Cardiomyopathy-Associated Genes in Acute Myocarditis
Emanuele Monda, Athanasios Bakalakos, Douglas Cannie, et al.
JACC Heart Failure (2024) Vol. 12, Iss. 6, pp. 1101-1111
Closed Access | Times Cited: 18
Molecular imaging in hypertrophic cardiomyopathy: an exploratory study with 2-[18F]FDG and [13N]NH3
Maria João Ferreira, Patrícia Marques‐Alves, Rodolfo Silva, et al.
EJNMMI Research (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Revisiting Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Current Practice and Novel Perspectives
A Ottaviani, Davide Mansour, Lorenzo V. Molinari, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 17, pp. 5710-5710
Open Access | Times Cited: 19
Maternal Nutrient Restriction Confers Myocardial Remodeling in Association with Dampened Autophagy and Mitophagy in Adult Sheep Offspring
Wei Ge, Qiurong Wang, Jun Tao, et al.
International Journal of Drug Discovery and Pharmacology (2025), pp. 100003-100003
Open Access
miRNAs Epigenetic Tuning of Wall Remodeling in the Early Phase after Myocardial Infarction: A Novel Epidrug Approach
Francesca Salvatori, Elisabetta D’Aversa, Maria Luisa Serino, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13268-13268
Open Access | Times Cited: 10
Immunosuppressive Agents—Effects on the Cardiovascular System and Selected Metabolic Aspects: A Review
Bianka Opałka, Michał Żołnierczuk, Marta Grabowska
Journal of Clinical Medicine (2023) Vol. 12, Iss. 21, pp. 6935-6935
Open Access | Times Cited: 9
Forward genetic screen using a gene-breaking trap approach identifies a novel role of grin2bb-associated RNA transcript (grin2bbART) in zebrafish heart function
Ramcharan Singh Angom, Adita Joshi, Ashok Patowary, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 3
Modeling cardiomyocyte signaling and metabolism predicts genotype-to-phenotype mechanisms in hypertrophic cardiomyopathy
Ali Khalilimeybodi, Jeffrey J. Saucerman, Padmini Rangamani
Computers in Biology and Medicine (2024) Vol. 175, pp. 108499-108499
Open Access | Times Cited: 3
Dapagliflozin, inflammation and left ventricular remodelling in patients with type 2 diabetes and left ventricular hypertrophy
Adel Dihoum, Alexander JM Brown, Rory J. McCrimmon, et al.
BMC Cardiovascular Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Inflammation, Oxidative Stress, and Endothelial Dysfunction in the Pathogenesis of Vascular Damage: Unraveling Novel Cardiovascular Risk Factors in Fabry Disease
Denise Cristiana Faro, Francesco Lorenzo Di Pino, Ines Monte
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8273-8273
Open Access | Times Cited: 3
Cell-autonomous and non-cell-autonomous effects of arginase-II on cardiac aging
Duilio Michele Potenza, Xin Cheng, Guillaume Ajalbert, et al.
(2024)
Open Access | Times Cited: 2
The Italian Fabry Disease Cardiovascular Registry (IFDCR)
Giuseppe Limongelli, Elena Biagini, Francesco Cappelli, et al.
European Heart Journal - Quality of Care and Clinical Outcomes (2024) Vol. 10, Iss. 6, pp. 483-487
Closed Access | Times Cited: 2
Uric acid and left ventricular hypertrophy: a gender-based meta-analysis of echocardiographic studies
Elisa Gherbesi, Andrea Faggiano, Carla Sala, et al.
Journal of Hypertension (2023)
Closed Access | Times Cited: 4
Diagnostic Puzzles and Cause-Targeted Treatment Strategies in Myocardial Infarction with Non-Obstructive Coronary Arteries: An Updated Review
Athanasios Samaras, Dimitrios V. Moysidis, Αndreas S. Papazoglou, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 19, pp. 6198-6198
Open Access | Times Cited: 4
Echocardiographic Phenotypes of Subclinical Organ Damage: Clinical and Prognostic Value in the General Population. Findings from the Pamela Study
Cesare Cuspidi, Andrea Faggiano, Giuseppe Mancia, et al.
High Blood Pressure & Cardiovascular Prevention (2023) Vol. 30, Iss. 6, pp. 497-511
Closed Access | Times Cited: 4
A Systematic Review on Safety and Efficacy of Migalastat for the treatment of Fabry’s Disease
Haya Majid, Neharika Verma, Shivani Bhandari, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 6, pp. 769-782
Closed Access | Times Cited: 1
Role of Cardiac Magnetic Resonance in Inflammatory and Infiltrative Cardiomyopathies: A Narrative Review
Davide Marchetti, Federica Buzzi, Riccardo Di Febo, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 16, pp. 4733-4733
Open Access | Times Cited: 1
Identification of Oxidative Stress-Related Biomarkers in Acute Myocardial Infarction
Yihan Sun, Min Wang, Xi Tan, et al.
International Journal of General Medicine (2023) Vol. Volume 16, pp. 4805-4818
Open Access | Times Cited: 3
Improvement in coronary microvascular dysfunction evaluated by cardiac magnetic resonance in patients with hypertrophic obstructive cardiomyopathy after transapical beating-heart septal myectomy
Yun Zhao, Lu Huang, Chenhe Li, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 2
Reply
Maria Chiara Meucci, Rosa E. Lillo, Francesca Graziani
Journal of the American College of Cardiology (2024) Vol. 83, Iss. 6, pp. e59-e59
Open Access
Dapagliflozin, Inflammation and Left Ventricular Remodelling in Patients with Type 2 Diabetes and Left Ventricular Hypertrophy
Adel Dihoum, Alexander JM Brown, Rory J. McCrimmon, et al.
Research Square (Research Square) (2024)
Open Access
Ceruloplasmin and Lipofuscin Serum Concentrations Are Associated with Presence of Hypertrophic Cardiomyopathy
Wiktoria Smyła-Gruca, Wioletta Szczurek, Michał Skrzypek, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1767-1767
Open Access
Definitional Challenges in Understanding Hypertrophic Cardiomyopathy
Jan M. Federspiel, Jochen Pfeifer, Frank Ramsthaler, et al.
Diagnostics (2024) Vol. 14, Iss. 22, pp. 2534-2534
Open Access
Diabetic microvascular complications are associated with left ventricular hypertrophy in patients with type 2 diabetes mellitus
Simo Liu, Jing Ke, Xiaotong Feng, et al.
Journal of Diabetes and its Complications (2024) Vol. 39, Iss. 2, pp. 108947-108947
Closed Access
Integrating urinary and plasma omics to identify markers and therapeutic targets for cardiac disease
Sophie C. de Ruiter, Marion van Vugt, Chris Finan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1 - Next Page

Scroll to top